How Big is the Uterine Fibroid Market | Industry Trends & Forecast 2025

Q: How does 6W market outlook report help businesses in making decisions?

6W monitors the market across 60+ countries Globally, publishing an annual market outlook report that analyses trends, key drivers, Size, Volume, Revenue, opportunities, and market segments. This report offers comprehensive insights, helping businesses understand market dynamics and make informed decisions.

Q: Do you also provide customisation in the market study?

Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com

Code: MTA9621

Publication Date: Sep 2025

How Big is the Uterine Fibroid Market?

According to 6Wresearch internal database and industry insights, the Uterine Fibroid Market was estimated at USD 4.2 billion in 2024 and is projected to reach USD 7.8 billion by 2031, expanding at a CAGR of 8.5% during the forecast period 2025-2031.

There are numbers of factors which are contributing in the expansion of the market include rising prevalence of uterine fibroids among women, increasing awareness of minimally invasive treatments, advancements in surgical and non-surgical interventions, growth in diagnostic procedures, and increasing healthcare spending on women health.

Key Growth Drivers of the Uterine Fibroid Market

Rising prevalence of uterine fibroids in women of reproductive age
Increasing adoption of minimally invasive surgical procedures
Advancements in medical therapies including hormone-based treatments
Expansion of diagnostic imaging technologies such as MRI and ultrasound
Growing awareness about treatment options and women health initiatives

Uterine Fibroid Market Trends

Uterine Fibroid Market is witnessing notable trends such as increasing preference for minimally invasive procedures like uterine artery embolization and laparoscopic surgery. Targeted medication therapies have become more prevalent to control symptoms and shrink fibroid size. Early diagnosis and treatment planning are being improved by the incorporation of advanced imaging techniques.

Due to they require less recovery time, outpatient and daycare procedures are becoming more popular. Telemedicine platforms are improving patient consultation and follow-up care. The market is seeing collaboration between healthcare providers and diagnostic service companies for improved treatment outcomes. Growing investment in research and clinical trials for novel therapies is supporting market development.

Emerging Developments in the Uterine Fibroid Market

Uterine Fibroid Market is evolving with advancements in non-invasive and minimally invasive therapies. Novel pharmacological treatments to reduce fibroids are still being developed. Research expenditures for energy-based ablation technologies have increased. Hospital stays are being decreased and patient accessibility is being improved by the expansion of outpatient care services.

Hospitals and medical device manufacturers are increasingly working together. The accuracy of detection is increasing with the use of AI-assisted imaging and diagnostics. Early diagnosis is being aided by the expansion of women health initiatives and awareness campaigns. Enhanced reimbursement policies and insurance coverage for fibroid treatments are supporting market growth.